Tag: PDE4 inhibitor

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to PDE4 inhibitor

Experts Highlight New Dermatological Treatments, Importance of Clinical Trial Diversity

Added to Collection on: 2024-09-14 11:06:45

Tags for this article:

Psoriasis
Organofluorides
PDE4 inhibitor
Roflumilast
Tapinarof
Desonide
Secukinumab
weill cornell

Click the tags to see associated articles and topics

View Article Details
Roflumilast Foam 0.3% Significantly Reduces Pruritus and Improves Quality of Life in Scalp ...

Added to Collection on: 2025-03-07 20:21:19

Tags for this article:

Psoriasis
PDE4 inhibitor
Roflumilast
Itch
Atopic dermatitis
Scalp pruritus
Calcipotriol/betamethasone dipropionate
Orlando
ARCUTIS BIOTHERAPEUTICS

Click the tags to see associated articles and topics

View Article Details
Real-World Data on the Adverse Effects of Apremilast and Deucravacitinib for Psoriasis

Added to Collection on: 2025-05-22 14:20:47

Tags for this article:

Autoimmune diseases
Psoriasis
Clinical research
Amgen
Apremilast
Phthalimides
Psoriatic arthritis
FDA Adverse Event Reporting System
Tyrosine kinase 2
Deucravacitinib
Pharmacovigilance
PDE4 inhibitor
u.s. food and drug administration

Click the tags to see associated articles and topics

View Article Details
Global Chronic Inducible Urticaria Market Set to Grow with Advances in Biologics and ...

Added to Collection on: 2025-08-31 12:35:59

Tags for this article:

Antiasthmatic drugs
Monoclonal antibodies
Hives
Type I hypersensitivity
Dupilumab
Omalizumab
Immunoglobulin E
Biopharmaceutical
Icos
PDE4 inhibitor
Ligelizumab
Autoimmune urticaria

Click the tags to see associated articles and topics

View Article Details
ALTO-101 Receives FDA Fast Track Designation for Treatment of Cognitive Impairment ...

Added to Collection on: 2025-10-03 18:27:04

Tags for this article:

PDE4 inhibitor
Schizophrenia
Electroencephalography
Cognition
Alto Neuroscience

Click the tags to see associated articles and topics

View Article Details
Alto Neuroscience Stock Soars Nearly 53% On FDA Fast Track Designation

Added to Collection on: 2025-10-03 17:56:31

Tags for this article:

Cognition
PDE4 inhibitor
Cognitive impairment
Alto Neuroscience Inc.
u.s. food and drug administration

Click the tags to see associated articles and topics

View Article Details
Book a Demo